Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Aldeyra Therapeutics, Inc. (ALDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Walker Neal (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Exercised 9,604 options to buy
@ $0.552, valued at
$5.3k
|
|
| 07/05/2023 |
4
| JOYCE MARTIN JOSEPH (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 21,222 options to buy
@ $8.39, valued at
$178.1k
Granted 640 options to buy
@ $8.39, valued at
$5.4k
Granted 2,744 options to buy
@ $8.39, valued at
$23k
|
|
| 07/05/2023 |
4
| Phillips Gary M. (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 21,222 options to buy
@ $8.39, valued at
$178.1k
Granted 1,829 options to buy
@ $8.39, valued at
$15.3k
Granted 1,372 options to buy
@ $8.39, valued at
$11.5k
|
|
| 07/05/2023 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 21,222 options to buy
@ $8.39, valued at
$178.1k
Granted 915 options to buy
@ $8.39, valued at
$7.7k
|
|
| 07/05/2023 |
4
| Bronstein Ben (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 21,222 options to buy
@ $8.39, valued at
$178.1k
Granted 1,372 options to buy
@ $8.39, valued at
$11.5k
Granted 1,464 options to buy
@ $8.39, valued at
$12.3k
|
|
| 07/05/2023 |
4
| DOUGLAS RICHARD (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 21,222 options to buy
@ $8.39, valued at
$178.1k
Granted 5,488 options to buy
@ $8.39, valued at
$46k
Granted 640 options to buy
@ $8.39, valued at
$5.4k
|
|
| 07/05/2023 |
4
| Walker Neal (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 21,222 options to buy
@ $8.39, valued at
$178.1k
Granted 915 options to buy
@ $8.39, valued at
$7.7k
|
|
| 06/29/2023 |
4
| Bronstein Ben (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Exercised 9,604 options to buy
@ $0.552, valued at
$5.3k
|
|
| 03/02/2023 |
4
| Machatha Stephen (Chief Development Officer) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 220,258 options to buy
@ $6.76, valued at
$1.5M
|
|
| 03/02/2023 |
4
| Greenberg Bruce (See Remarks) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 110,028 options to buy
@ $6.76, valued at
$743.8k
|
|
| 03/02/2023 |
4
| Brady Todd C (President and CEO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 238,750 shares
@ $0
Granted 250,000 options to buy
@ $6.76, valued at
$1.7M
|
|
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Bought 144,185 shares
@ $5.05, valued at
$728.1k
|
|
| 08/02/2022 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Bought 222,123 shares
@ $5.03, valued at
$1.1M
|
|
| 08/01/2022 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Bought 119,392 shares
@ $5, valued at
$597k
|
|
| 07/19/2022 |
4
| Brady Todd C (President and CEO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 604,308 options to buy
@ $0 |
|
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Machatha Stephen (Chief Development Officer) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 185,605 shares
@ $0
Granted 69,473 options to buy
@ $0 |
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Brady Todd C (President and CEO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Bought 17,700 shares
@ $3.3642, valued at
$59.5k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 53,812 options to buy
@ $3.6, valued at
$193.7k
Granted 2,319 options to buy
@ $3.6, valued at
$8.3k
|
|
| 06/09/2022 |
4
| Phillips Gary M. (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 53,812 options to buy
@ $3.6, valued at
$193.7k
Granted 4,639 options to buy
@ $3.6, valued at
$16.7k
Granted 3,479 options to buy
@ $3.6, valued at
$12.5k
|
|
| 06/09/2022 |
4
| Bronstein Ben (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 53,812 options to buy
@ $3.6, valued at
$193.7k
Granted 3,479 options to buy
@ $3.6, valued at
$12.5k
Granted 3,711 options to buy
@ $3.6, valued at
$13.4k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Walker Neal (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 53,812 options to buy
@ $3.6, valued at
$193.7k
Granted 2,319 options to buy
@ $3.6, valued at
$8.3k
|
|
| 04/01/2022 |
4
| Brady Todd C (President and CEO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 250,000 shares
@ $0
Granted 250,000 options to buy
@ $4.52, valued at
$1.1M
Granted 207,758 options to buy
@ $0 |
|
| 04/01/2022 |
4
| Reed Joshua (CFO) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 93,322 shares
@ $0
Granted 250,000 options to buy
@ $4.52, valued at
$1.1M
|
|
| 04/01/2022 |
4
| Machatha Stephen (Chief Development Officer) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 64,395 shares
@ $0
Granted 250,000 options to buy
@ $4.52, valued at
$1.1M
|
|
|
|
|